Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The journals of gerontology. Series A, Biological sciences and medical sciences

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/GERONA/63.4.369PMID 18426960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An operational definition of frailty predicted death, hip fracture, and hospitalization in older women.

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Statin use and functional decline in patients with and without peripheral arterial disease.

  2006cited by this paper
• Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults

  2006cited by this paper
• An assessment of statin safety by muscle experts.

  2006cited by this paper
• Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.

  2006cited by this paper
• Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins

  2005cited by this paper
• Frailty: Emergence and Consequences in Women Aged 65 and Older in the Women's Health Initiative Observational Study

  2005influential reference
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Inflammatory Markers and Incident Mobility Limitation in the Elderly

  2004cited by this paper
• Frailty--the search for underlying causes.

  2004cited by this paper
• Implementation of the Women's Health Initiative study design.

  2003cited by this paper
• The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.

  2003cited by this paper
• Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease

  2003cited by this paper
• Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

  2003cited by this paper
• Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.

  2003cited by this paper
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

  2003cited by this paper
• Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease

  2003cited by this paper
• Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Walking compared with vigorous exercise for the prevention of cardiovascular events in women.

  2002cited by this paper
• Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels

  2002cited by this paper
• Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Associations of subclinical cardiovascular disease with frailty.

  2001cited by this paper
• Frailty in older adults: evidence for a phenotype.

  2001influential reference
• Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview.

  2001cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Assessment and Control for Confounding by Indication in Observational Studies

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Serum IL‐6 Level and the Development of Disability in Older Persons

  1999cited by this paper
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

  1998cited by this paper
• Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

  1998cited by this paper
• Compendium of physical activities: classification of energy costs of human physical activities.

  1993cited by this paper
• Development of a Brief Screening Instrument for Detecting Depressive Disorders

  1988cited by this paper
• The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link

  year unknowncited by this paper

• Medication Use by Older Adults with Frailty: A Scoping Review

  2025cites this paper
• What Do We Know About Prevention of Frailty in Women?

  2025cites this paper
• Association of the atherogenic index of plasma with frailty in U.S. adults: a cross-sectional study based on NHANES

  2025cites this paper
• Association between Drug Therapy and Risk of Incident Frailty: A Systematic Review

  2024cites this paper
• Association between inflammatory markers, body composition and frailty in home-dwelling elderly: an 8-year follow-up study

  2024cites this paper
• Sex-specific interventions to prevent and manage frailty.

  2022cites this paper
• The association between medication or alcohol use and the incidence of frailty: a retrospective cohort study

  2021cites this paper
• Research progress of gut microbiota and frailty syndrome

  2021cites this paper
• STATIN USE, DEVELOPMENT OF SARCOPENIA AND LONG-TERM SURVIVAL AFTER ENDOVASCULAR AORTIC REPAIR.

  2021cites this paper
• Frailty in Rheumatic Diseases

  2020cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• Differences in frailty in older men and women

  2019cites this paper
• Frailty and coronary plaque characteristics on optical coherence tomography

  2019cites this paper
• Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank

  2019cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• Inflammatory Markers and Frailty

  2018cites this paper
• Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

  2018cites this paper
• The association between frailty and medicines use over time: an analysis using the Australian Longitudinal Study on Ageing population

  2018cites this paper
• Association between statin use and physical function among community‐dwelling older Japanese adults

  2018cites this paper
• Inflammation Strikes Again: Frailty and HIV

  2018cites this paper
• Preventing cardiovascular disease in older adults: One size does not fit all

  2018cites this paper
• Inappropriate pharmacological treatment in older adults affected by cardiovascular disease and other chronic comorbidities: a systematic literature review to identify potentially inappropriate prescription indicators

  2017cites this paper
• Association between body composition and hip fractures in older women with physical frailty

  2017cites this paper
• Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification.

  2017cites this paper
• Définition de la fragilité à partir des critères retenus dans la littérature

  2017cites this paper
• Prescribing for frail older people.

  2017cites this paper
• Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease.

  2016cites this paper
• Sarcopenia Is Associated With Lower Skeletal Muscle Capillarization and Exercise Capacity in Older Adults.

  2016cites this paper
• [Medicines and frailty in older people. Towards a new nosological entity: A pharmacological frailty?].

  2016cites this paper
• Association of dynamics in lean and fat mass measures with mortality in frail older women

  2016cites this paper
• Association Between Anthropometric Measures and Long‐Term Survival in Frail Older Women: Observations from the Women's Health Initiative Study

  2016cites this paper
• The importance of frailty in lung transplantation and chronic lung disease

  2016cites this paper
• Pharmacoepidemiology and Pharmacovigilance for Safety and Efficacy in Older People

  2016cites this paper
• Statin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study

  2015cites this paper
• Application of new guidelines for the primary prevention of atherosclerotic cardiovascular disease in a Korean population.

  2015cites this paper
• Factors Associated with Nursing Home Admission after Stroke in Older Women.

  2015cites this paper
• Australian and New Zealand Society for Geriatric Medicine

  2015cites this paper
• Depression and frailty in later life: a systematic review

  2015cites this paper
• Statin Use and Decline in Gait Speed in Community‐Dwelling Older Adults

  2015cites this paper
• Association Between Statin Use at Admission to Inpatient Rehabilitation and Functional Status at Discharge among Older Patients

  2014cites this paper
• Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

  2014cites this paper
• Evaluation and treatment of older patients with hypercholesterolemia: a clinical review.

  2014cites this paper
• OPINION Statins in the elderly: an answered question?

  2014cites this paper
• Lipid-lowering drugs associated with slower motor decline in the elderly adults.

  2014cites this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cites this paper
• Frailty syndrome: an overview

  2014cites this paper
• Statins in the elderly: an answered question?

  2014cites this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cites this paper
• 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• Unsecured consumer debt and mental health outcomes in middle-aged and older Americans.

  2014cites this paper
• Statin use and clinical outcomes in older men: a prospective population-based study

  2013cites this paper
• Pharmacoepidemiologic studies: An interrupted-time series analysis on drug utilization and evaluation of beneficial or adverse drug effects

  2013cites this paper
• Statins in older adults

  2013cites this paper
• Frailty in older age in the Whitehall II study: Measurement, validation, and predictive algorithms

  2013cites this paper
• Emerging drug therapies for frailty.

  2013cites this paper
• Prestroke Factors Associated with Poststroke Mortality and Recovery in Older Women in the Women's Health Initiative

  2013cites this paper
• Heart Association Task Force on Practice Guidelines Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic

  2013cites this paper
• Statins, Angiotensin‐Converting Enzyme Inhibitors, and Physical Performance in Older Women

  2012cites this paper
• High-risk prescribing in older people: more harm than good?

  2012cites this paper
• CHAPTER 8 General discussion

  2012cites this paper
• Longitudinal Dynamics in Indicators of Frailty: Predictors and Long-Term Outcomes

  2012cites this paper
• High‐Risk Prescribing and Incidence of Frailty Among Older Community‐Dwelling Men

  2012cites this paper
• Association Between Use of Statin Medication and Weight Change in Older Men

  2012cites this paper
• eview merging drug therapies for frailty hristopher

  2012cites this paper
• Frailty in older inpatients: what physicians need to know.

  2012cites this paper
• Interventions targeting geriatric frailty: A systemic review

  2012cites this paper
• Disability in older people with diabetes: issues for the clinician:

  2012cites this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cites this paper
• Telomere Length in Old Age and Cholesterol Across the Life Course

  2011cites this paper
• Frailty, inflammation, and immunity.

  2011cites this paper
• Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study

  2011cites this paper
• The Frailty Syndrome: A Comprehensive Review

  2011cites this paper
• The epidemiology of sarcopenia in community living older adults: what role does lifestyle play?

  2011cites this paper
• Current and future pharmacologic treatment of sarcopenia.

  2011cites this paper
• Frailty in older people

  2011cites this paper
• Frailty and chronic diseases in older adults.

  2011cites this paper
• Is Frailty Associated with Cardiovascular Drug Use?

  2011cites this paper
• Constipation and risk of cardiovascular disease among postmenopausal women.

  2011cites this paper
• Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric Assessment

  2010cites this paper
• Frailty, inflammation and the elderly

  2010cites this paper
• Protein Intake and Incident Frailty in the Women's Health Initiative Observational Study

  2010influential citation
• Frailty among HIV-infected persons in an urban outpatient care setting.

  2009cites this paper
• Non-Atheroprotective Effects of Statins

  2009cites this paper
• Health-and disease-related biomarkers in aging research.

  2009cites this paper
• Statin therapy, muscle function and falls risk in community-dwelling older adults.

  2009cites this paper